Libtayo (cemiplimab)
pCPA File Number:
21794
Negotiation Status:
Concluded without agreement
Indication(s):
For the treatment of patients with locally advanced basal cell carcinoma (BCC) previously treated with a hedgehog pathway inhibitor
Sponsor/Manufacturer:
Sanofi-Aventis Canada Inc.
CDA-AMC Project Number:
PC0260-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: